Jordan University of Science and Technology
Irbid, 22110, Jordan
NCT Number: NCT03902288
Fresh pomegranate juice at 1.5 mL/kg of body weight was administered by recruited healthy individuals and patients with type 2 diabetes of fasting serum glucose between 7.1 and 15.8 mmol/L after approximately 12 hours fasting. Blood samples were collected in plain tubes before (-5 minutes) and at 1 and 3 hours after drinking pomegranate juice. Blood samples were centrifuged and serum was collected and stored for glucose and hormonal analysis. Patients were recruited from those of earlier stages of type 2 diabetes, and many of them already drink pomegranate juice as of its benefits for their health).
The exclusion criteria included subjects with renal or hepatic disease, pregnancy, treatment with insulin, and hormone therapies. Participants who had either smoked cigarettes or taken antioxidant supplements, lipid-lowering drugs, and oral hypoglycemic agents, such as metformin (glucophage) or sulfonylureas, within the preceding 12 hours were also excluded.
The study was explained to all of the recruited subjects by the clinical researchers, and written informed consent was obtained prior to enrollment. Approval for the study was provided by the IRB Committee at Jordan University of Science and Technology (Irbid, Jordan).
Looking for future studies?
Notify Me35 year–60 year
All sexes
Interventional
Not applicable
Irbid, 22110, Jordan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pomegranate seeds (arils) were separated by hand, and fresh pomegranate juice was prepared by squeezing the seeds using a fruit squeezing machine. Fresh pomegranate juice was given at 1.5 mL/kg of body weight for the fasted recruited patient with type 2 diabetes (FSG < 15.8 mmol/L). Blood was collected before and after 1 and 3 hours of ingesting the juice.
Time frame: 1 - 3 hours
Measuring the alteration in fasting serum glucose in mmol/L before and at 1 and 3 hours following pomegranate juice ingestion
Time frame: 1 - 3 hours
Measuring insulin in μIU/mL before and at 1 and 3 hours following pomegranate juice ingestion
Time frame: 1 - 3 hours
Measuring erythropoietin in mIU/mL before and at 1 and 3 hours following pomegranate juice ingestion
Time frame: 1 - 3 hours
Measuring erythropoietin in μg/dL before and at 1 and 3 hours following pomegranate juice ingestion
Time frame: 1 -3 hours
Measuring erythropoietin in nmol/L before and at 1 and 3 hours following pomegranate juice ingestion
Time frame: 1 - 3 hours
Measuring Melatonin in pg/mL before and at 1 and 3 hours following pomegranate juice ingestion
Time frame: 1 - 3 hours
Measuring testosterone in ng/dL before and at 1 and 3 hours following pomegranate juice ingestion
Time frame: 1 - 3 hours
Measuring aldosterone in ng/dL before and at 1 and 3 hours following pomegranate juice ingestion
Time frame: 1 - 3 hours
Measuring serum total antioxidant activity in Trolox equivalents before and at 1 and 3 hours following pomegranate juice ingestion
Jordan University of Science and Technology
Other
Fresh Pomegranate Juice Decreases Fasting Serum Erythropoietin in Patients With Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.